Pemgarda is an investigational medicine authorized for pre-exposure prophylaxis to prevent COVID-19 in adults and children aged 12 and older with moderate-to-severe immune compromise who are unlikely to respond to vaccination.
It is not authorized for COVID-19 treatment, post-exposure prevention, or for use in children under 12 or weighing less than 88 pounds, and does not replace COVID-19 vaccination.
Pemgarda is a monoclonal antibody therapy, which involves antibodies created in a laboratory. These antibodies bind to the spike protein of SARS-CoV-2, the virus responsible for COVID-19, blocking the virus from entering the body’s cells.
1 hour
As prescribed by a physician
Pemgarda cost can vary depending on several factors including insurance status and insurance provider. At Pure Infusion Suites, we are committed to lowering costs and improving access for our patients. Our team of patient access coordinators are here to set you up for success.
We work with a growing list of insurance providers, and are always working to ensure claims/authorizations are processed efficiently. All patients are enrolled in co-pay assistance programs to assist in covering costs of treatment.
Additionally, data from an Artemetrx report shows average costs at an outpatient hospital facility are more than 3X higher than costs at an ambulatory infusion center. That means we save our patients’ money, while offering a more comfortable experience!
Before your infusion, it is important to drink plenty of water and come to your appointment hydrated. Additionally, you must alert us as soon as possible to any changes in your insurance to ensure that we are still an in-network provider for your infusion therapy.